Sign Up Today and Learn More About Allay Therapeutics Stock
Invest in or calculate the value of your shares in Allay Therapeutics or other pre-IPO companies through EquityZen's platform.
Allay Therapeutics Stock (ALTR)
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
About Allay Therapeutics Stock
Founded
2017
Headquarters
Menlo Park, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Allay Therapeutics Press Mentions
Stay in the know about the latest news on Allay Therapeutics
Deals in brief: Atome secures USD 75 million facility, Sam Altman backs Coco Robotics again, 12 new China deals, and more
kr-asia • Jun 12, 2025
Allay Therapeutics: $57.5 Million Funding Raised For Advancing ATX101
pulse2 • Jun 11, 2025
Allay’s $57.5M extends postsurgical pain relief with ATX-101
bioworld • Jun 11, 2025
Temasek's ClavystBio, Lightstone Ventures back Allay Therapeutics' $57.5M Series D financing
technode • Jun 09, 2025
The Week’s Biggest Funding Rounds: Defense Tech Leads Week With Anduril’s $2.5B Raise
news • Jun 07, 2025
Allay Therapeutics Management
Leadership team at Allay Therapeutics
Board Member
Nicole Walker
Board Member
Tak Cheung
Join now and verify your accreditation status to gain access to:
- Allay Therapeutics Current Valuation
- Allay Therapeutics Stock Price
- Allay Therapeutics Management
- Available deals in Allay Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Allay Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Allay Therapeutics Revenue and Financials
- Allay Therapeutics Highlights
- Allay Therapeutics Business Model
- Allay Therapeutics Risk Factors
- Allay Therapeutics Research Report from SACRA Research
Trading Allay Therapeutics Stock
How to invest in Allay Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Allay Therapeutics through EquityZen funds. These investments are made available by existing Allay Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Allay Therapeutics stock?
Shareholders can sell their Allay Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
